meRfi®-GM
Acquired Immune Deficiency Syndrome (AIDS) / HIV
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Oral pre-exposure prophylaxis has been introduced in more than 70 countries, including many in sub-Saharan Africa, but women experience considerable barriers to daily pill-taking, such as stigma, judgement, and the fear of violence. Safe and effective long-acting agents for HIV prevention are needed for women
…
References (Sources)
- Bacterial vaginosis and HIV acquisition: a meta-analysis of published studiesMeta-Analysis
- Disparate Associations of HLA Class I Markers with HIV-1 Acquisition and Control of Viremia in an African Population
- HIV
- Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015
- Targeting the N332-supersite of the HIV-1 envelope for vaccine design
- The importance of targeting HIV reservoirs: preclinical insights on current and potential therapeutic opportunities
- Why and where an HIV cure is needed and how it might be achieved